XML 19 R8.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Cash flows from operating activities      
Net earnings $ 5,337 $ 4,359  
Adjustments to reconcile net earnings to net cash provided from operating activities:      
Depreciation 1,003 780  
Amortization 348 257  
Deferred taxes (43) 0  
Premium amortization, net of discount accretion 943 1,065  
Gain on sale of loans (477) (556)  
Provision for loan losses 575 600 $ 2,250
Origination of loans held for sale (13,560) (16,412)  
Proceeds from loans held for sale 14,610 17,387  
Write-down of other real estate and repossessed assets 10 0  
Net loss on sale of premises, equipment, other real estate owned and other assets (34) (7)  
Stock based compensation 137 117  
Net change in accrued interest receivable and other assets (9,826) 685  
Net change in accrued interest payable and other liabilities 11,302 593  
Net cash provided by operating activities 10,325 8,868  
Securities available for sale:      
Purchases (5,120) (13,156)  
Proceeds from maturities and principal repayments 5,855 6,098  
Securities held to maturity:      
Proceeds from maturities and principal repayments 1,666 3,721  
Net purchases of premises and equipment (1,154) (2,059)  
Net proceeds from sale of premises, equipment, other real estate owned and other assets 296 407  
Net repayments (originations) of loans 3,760 (41,922)  
Net cash provided by (used in) investing activities 5,303 (46,911)  
Cash flows from financing activities      
Net change in deposits 90,821 15,262  
Net change in securities sold under agreements to repurchase (686) (484)  
Proceeds from FHLB advances 56,000 20,000  
Repayment of FHLB advances (121,005) (4)  
Repayments of debentures (500)    
Purchase of treasury stock (1,932)    
Exercise of stock options 481    
Cash dividends (2,013) (1,548)  
Net cash provided by financing activities 21,166 33,226  
Net change in cash and cash equivalents 36,794 (4,817)  
Cash and cash equivalents at beginning of period 71,510 91,428 91,428
Cash and cash equivalents at end of period 108,304 86,611 $ 71,510
Supplemental disclosures of cash flow information      
Interest paid 6,174 3,539  
Supplemental schedule of noncash investing and financing activities      
Purchase of treasury stock accrued 283    
Cash dividends accrued 2,008 1,548  
Transfer loans to other real estate owned and repossessed assets $ 130 $ 188